Unsafe Drugs and Medical Products

Our civil trial attorneys have an average of over 25 years of experience in litigating complex personal injury, products liability, mass torts, and medical malpractice claims.  We have successfully represented over 10,000 plaintiffs in pharmaceutical and medical device claims involving Vioxx, Bextra, hormone replacement therapy drugs, Guidant and Medtronic heart devices, breast implants, diet drugs, Baycol, Sulzer hip and knee implants, PPA, ProteGen bladder slings, and ReNu contact lens solution, just to name a few examples.  Alley, Clark & Greiwe is actively involved in litigation on a number of drug and medical device claims including the following projects:

Current Unsafe Drugs and Medical Device Projects:

• Hip Implants – DePuy ASR Hip Implant
• Hip Implants – Zimmer Durom Cup Hip Implant
• Vaginal Mesh Litigation
• Vaginal Mesh – Bard Avaulta Surgical Mesh
• Accutane
• Actos
• Avandia
• Bard Avaulta Surgical Mesh
• Bisphosphonate Litigation
• Chantix
• Darvon and Darvocet Recall
• Fen-Phen Diet Drugs
• Hip Implants – Zimmer Durom Cup Hip Implant
• Hip Implants – DePuy ASR Hip Implant
• Hormone Replacement Drugs
• Knee Implant – Zimmer NexGen CR-Flex
• Kugel Hernia Mesh Patches
• Medtronic Sprint Fidelis Lead
• Mentor ObTape Vaginal Sling
• Ortho Evra Birth Control Patch
• Pain Pumps
• Poligrip and Fixodent Denture Creams
• Vaginal Mesh – Bard Avaulta Surgical Mesh
• Yasmin Birth Control
• Zocor
• Other/Archive Drug Products

Please visit our Verdicts & Settlements Section for information about some of our previous drug and medical device settlements.  If you or someone you love has been harmed by an unsafe drug or medical product, please contact the experienced attorneys at Alley, Clark & Greiwe for a free consultation regarding your legal rights.

News Archive:

• Government Accountability Office declares the FDA is in dire need of improvement
• Controversy erupts between U.S. Department of Health and FDA over missing financial data
• FDA scientists complain of widespread managerial misconduct
• Clinical Trial Participants Get Little FDA Protection
• FDA Plans to Accelerate Generic Drug Review
• Merck Sued by State of New York Over Vioxx
• State Suing Drug Companies for Fraud
• FDA Appoints Members of Risk Communication Panel
• Advisory Panel Says FDA Needs Recall Power
• GE Facing Litigation Over MRI Drug Omniscan